Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J O'Shaughnessy

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Urologic Clinics of North America|July 29, 2015
Late Relapse of Testicular Germ Cell TumorsMatthew J O'Shaughnessy, Darren R Feldman, Brett S Carver, et al.
Urology|March 11, 2017
Author ReplyMatthew J O'Shaughnessy, Sean M McBride, Hebert Alberto Vargas, et al.
The Journal of Urology|June 25, 2014
Bladder biopsy of normal-appearing mucosa is not helpful in patients with unexplained positive cytology after nonmuscle invasive bladder cancerJohn E Musser, Matthew J O'Shaughnessy, Philip H Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivoChristine Vogtenhuber, Matthew J O'Shaughnessy, Dario A A Vignali, et al.
Urology|March 8, 2013
Factors associated with reduction in use of neoadjuvant androgen suppression therapy before radical prostatectomyMatthew J O'Shaughnessy, Stephanie L Jarosek, Beth A Virnig, et al.
Nature Reviews. Clinical Oncology|October 18, 2017
Drug development for noncastrate prostate cancer in a changed therapeutic landscapeMin Yuen Teo, Matthew J O'Shaughnessy, Sean M McBride, et al.
Nature Reviews. Clinical Oncology|November 9, 2017
Drug development for noncastrate prostate cancer in a changed therapeutic landscapeMin Yuen Teo, Matthew J O'Shaughnessy, Sean M McBride, et al.
Blood|March 1, 2003
IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell functionZong-ming Chen, Matthew J O'Shaughnessy, Irene Gramaglia, et al.
Blood|May 22, 2009
Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of alloprimingSteven L Highfill, Ryan M Kelly, Matthew J O'Shaughnessy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivoMatthew J O'Shaughnessy, Zong-Ming Chen, Irene Gramaglia, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Urologic Clinics of North America|July 29, 2015
Late Relapse of Testicular Germ Cell TumorsMatthew J O'Shaughnessy, Darren R Feldman, Brett S Carver, et al.
Urology|March 11, 2017
Author ReplyMatthew J O'Shaughnessy, Sean M McBride, Hebert Alberto Vargas, et al.
The Journal of Urology|June 25, 2014
Bladder biopsy of normal-appearing mucosa is not helpful in patients with unexplained positive cytology after nonmuscle invasive bladder cancerJohn E Musser, Matthew J O'Shaughnessy, Philip H Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivoChristine Vogtenhuber, Matthew J O'Shaughnessy, Dario A A Vignali, et al.
Urology|March 8, 2013
Factors associated with reduction in use of neoadjuvant androgen suppression therapy before radical prostatectomyMatthew J O'Shaughnessy, Stephanie L Jarosek, Beth A Virnig, et al.
Nature Reviews. Clinical Oncology|October 18, 2017
Drug development for noncastrate prostate cancer in a changed therapeutic landscapeMin Yuen Teo, Matthew J O'Shaughnessy, Sean M McBride, et al.
Nature Reviews. Clinical Oncology|November 9, 2017
Drug development for noncastrate prostate cancer in a changed therapeutic landscapeMin Yuen Teo, Matthew J O'Shaughnessy, Sean M McBride, et al.
Blood|March 1, 2003
IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell functionZong-ming Chen, Matthew J O'Shaughnessy, Irene Gramaglia, et al.
Blood|May 22, 2009
Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of alloprimingSteven L Highfill, Ryan M Kelly, Matthew J O'Shaughnessy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivoMatthew J O'Shaughnessy, Zong-Ming Chen, Irene Gramaglia, et al.
Pageof 2